Though DOT1L has not yet been implicated in CML, its significant role in the development of MLL -rearranged (MLL-r) leukemia is supported by accumulated evidence [58]. This evidence concerns the gene DOT1L and chronic myelogenous leukemia, BCR-ABL1 positive.